Fareston 60mg Tablets

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Fareston is and what it is used for
2. What you need to know before you take Fareston
3. How to take Fareston
4. Possible side effects
5. How to store Fareston
6. Contents of the pack and other information

• if you are allergic to toremifene or any of the other ingredients of this medicine (listed in section 6).
• if you have a thickening of the womb lining
• if you have severe liver problems
• if you were born with or have had any condition which causes certain abnormal changes in the electrical recording of the heart (electrocardiogram or ECG)
• if you have a salt imbalance in the blood, especially low concentrations of potassium in the blood (hypokalaemia) which are currently not corrected by treatment
• if you have a very slow heart rate (bradycardia)
• if you have a heart failure
• if you have a history of abnormal heart rhythms (arrhythmias)
• if you are taking other medicines that may affect your heart (see section 2 Other medicines and Fareston).
  This is because Fareston can affect your heart by delaying the conduction of electrical signals within your heart (prolongation of QT-interval).

Talk to your doctor or pharmacist before taking Fareston:

• if you have unstable diabetes
• if your general well-being is severely deteriorated
• if you have previously had a condition in which blood clots formed in blood vessels, for example in your lungs (lung embolism) or in the veins of your legs (deep vein thrombosis).
• if you experience an abnormal heart rhythm whilst taking Fareston. Your doctor may advise you to stop taking Fareston and perform a medical test to see how your heart is working (ECG). (see section 2 Do not take Fareston)
• if you have any heart condition, including chest pain (angina)
• if your cancer has spread to the bones (bone metastasis) as calcium blood levels may increase at the beginning of treatment with Fareston. Your doctor will conduct regular medical check-ups.
• if you have been told by your doctor that you have an intolerance to certain sugars, like lactose (see section 2 Fareston contains lactose).

You should have gynaecological examinations before you start treatment with Fareston and at least once a year following the start of treatment with Fareston. Your doctor will conduct regular medical check-ups if you have high blood pressure, diabetes, have taken hormone replacement therapy or if you are obese (BMI over 30).

Tell your doctor if you are taking, have recently taken or might take any other medicines. The dose of some of these may have to be adjusted while you are on Fareston. In particular please tell your doctor if you are taking any of the following:

• water tablets (diuretics of thiazide type)
• medicines to prevent blood clotting such as warfarin
• medicines used to treat epilepsy such as carbamazepine, phenytoin, phenobarbital
• medicines used to treat fungal infections such as ketoconazole, itraconazole, voriconazole, posaconazole
• medicines used to treat bacterial infections (antibiotics) such as erythromycin, clarithromycin and telithromycin
• medicines used to treat viral infection such as ritonavir and nelfinavir.

Do not take Fareston together with the following medicines as there is an increased risk that your heartbeat may be altered (see section 2 Do not take Fareston):

• medicines used to treat abnormal heart rhythm (antiarrhythmics); such as quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide and ibutilide
• medicines used to treat mental and behavioral disorders (neuroleptics); such as phenothiazines, pimozide, sertindole, haloperidol and sultopride
• medicines used to treat infections (antimicrobials); such as moxifloxacin, erythromycin (infusion) pentamidine and antimalarials (particularly halofantrine)
• certain medicines to treat allergies; such as terfenadine, astemizole and mizolastine
• others; cisapride, intravenous vincamine, bepridil, diphemanil.

If you are admitted to the hospital or if you are prescribed a new medicine, please tell your doctor that you are taking Fareston.

Do not use Fareston during pregnancy or breast feeding.

Fareston has no influence on the ability to drive and use machines.

Fareston contains 28.5 mg lactose (as monohydrate) per tablet. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

This medicine contains less than 1 mmol (23 mg) sodium per tablet that is to say essentially ‘sodium-free’.

Contact your doctor, pharmacist or the nearest hospital immediately. Symptoms of overdose may be dizziness and headache.

If you miss one dose take the next tablet as usual and continue treatment as recommended. Do not take a double dose to make up for a forgotten tablet. If you have missed several doses, please inform your doctor and follow his instructions.

The treatment with Fareston should only be stopped when advised by your doctor.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

• The active substance is toremifene; each tablet contains 60 mg (as citrate).
• The other ingredients are maize starch, lactose monohydrate, povidone, sodium starch glycolate, microcrystalline cellulose, colloidal anhydrous silica and magnesium stearate.

White, round, flat, bevelled edge tablet with TO 60 on one side.

30 and 100 tablets. Not all pack sizes may be marketed.

For any information about this human medicinal product, please contact the local representative of the marketing authorisation holder.